114 related articles for article (PubMed ID: 6322659)
1. Immunologic and biological properties and clinical significance of placental proteins PP5 and PP12.
Seppälä M; Rutanen EM; Siiteri JE; Wahlström T; Koistinen R; Pietilä R; Bohn H
Ann N Y Acad Sci; 1983; 417():368-82. PubMed ID: 6322659
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoassay of placental protein 12: levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women, and patients with trophoblastic disease.
Rutanen EM; Bohn H; Seppälä M
Am J Obstet Gynecol; 1982 Oct; 144(4):460-3. PubMed ID: 6289668
[TBL] [Abstract][Full Text] [Related]
3. Levels of placenta-specific tissue protein 12 (PP12) in serum during normal pregnancy and in patients with trophoblastic tumour.
Than GN; Csaba IF; Szabó DG; Bognár ZJ; Arany A; Bohn H
Arch Gynecol; 1983; 234(1):39-46. PubMed ID: 6318674
[TBL] [Abstract][Full Text] [Related]
4. Placental protein 5 is related to blood coagulation and fibrinolytic systems.
Siiteri JE; Koistinen R; Salem HT; Bohn H; Seppälä M
Life Sci; 1982 May; 30(22):1885-91. PubMed ID: 6213827
[TBL] [Abstract][Full Text] [Related]
5. Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.
Lee JN; Salem HT; Chard T; Huang SC; Ouyang PC
Br J Obstet Gynaecol; 1982 Jan; 89(1):69-72. PubMed ID: 6277363
[TBL] [Abstract][Full Text] [Related]
6. Placental protein 5 in gestational trophoblastic disease: localization and circulating levels.
Nisbet AD; Bremner RD; Horne CH; Brooker D; Twiggs LB; Okagaki T
Am J Obstet Gynecol; 1982 Oct; 144(4):396-401. PubMed ID: 6289667
[TBL] [Abstract][Full Text] [Related]
7. New placental proteins: chemistry, physiology and clinical use.
Rosen SW
Placenta; 1986; 7(6):575-94. PubMed ID: 2432592
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and trophoblastic disease: absence of PP5 expression in the malignant trophoblast.
Seppälä M; Wahlström T; Bohn H
Int J Cancer; 1979 Jul; 24(1):6-10. PubMed ID: 225283
[No Abstract] [Full Text] [Related]
9. Two fetal antigens (FA-1 and FA-2) and endometrial proteins (PP12 and PP14) isolated from amniotic fluid; preliminary observations in fetal and maternal tissues.
Fay TN; Jacobs I; Teisner B; Poulsen O; Chapman MG; Stabile I; Bohn H; Westergaard JG; Grudzinskas JG
Eur J Obstet Gynecol Reprod Biol; 1988 Sep; 29(1):73-85. PubMed ID: 3224746
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical demonstration of placental protein 5 in trophoblastic tumours.
Lee JN; Wahlström T; Seppälä M; Salem HT; Ouyang PC; Chard T
Placenta; 1982; 3(1):67-70. PubMed ID: 6281754
[TBL] [Abstract][Full Text] [Related]
11. Placental protein 12 (PP12) in menstrual fluid.
Rutanen EM; Koistinen R; Wahlström T; Stenman UH; Seppälä M
Br J Obstet Gynaecol; 1984 Oct; 91(10):1025-30. PubMed ID: 6386037
[TBL] [Abstract][Full Text] [Related]
12. Purification of placental protein PP12 from human amniotic fluid and its comparison with PP12 from placenta by immunological, physicochemical and somatomedin-binding properties.
Koistinen R; Huhtala ML; Stenman UH; Seppälä M
Clin Chim Acta; 1987 May; 164(3):293-303. PubMed ID: 3109787
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of pregnancy-specific protein (SP1) and placenta-specific tissue proteins (PP5, PP10, PP11 and PP12) in ovarian adenocarcinomas.
Inaba N; Ishige H; Ijichi M; Satoh N; Ohkawa R; Sekiya S; Shirotake S; Takamizawa H; Renk T; Bohn H
Oncodev Biol Med; 1982; 3(5-6):379-89. PubMed ID: 6755403
[TBL] [Abstract][Full Text] [Related]
14. Placental protein 12 (PP12): factors affecting levels in late pregnancy.
Rutanen EM; Seppälä M; Pietilä R; Bohn H
Placenta; 1984; 5(3):243-8. PubMed ID: 6542215
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy proteins in seminal plasma, seminal vesicles, preovulatory follicular fluid, and ovary.
Seppälä M; Koskimies AI; Tenhunen A; Rutanen EM; Sjöberg J; Koistinen R; Julkunen M; Wahlström T
Ann N Y Acad Sci; 1985; 442():212-26. PubMed ID: 3893267
[TBL] [Abstract][Full Text] [Related]
16. Placental protein 12 (PP12) in primary liver cancer and cirrhosis.
Rutanen EM; Wahlström T; Koistinen R; Sipponen P; Jalanko H; Seppälä M
Tumour Biol; 1984; 5(2):95-102. PubMed ID: 6209778
[TBL] [Abstract][Full Text] [Related]
17. The binding characteristics and biological effects in FRTL5 cells of placental protein-12, an insulin-like growth factor-binding protein purified from human amniotic fluid.
Frauman AG; Tsuzaki S; Moses AC
Endocrinology; 1989 May; 124(5):2289-96. PubMed ID: 2707157
[TBL] [Abstract][Full Text] [Related]
18. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
Lee JN; Salem HT; Al-Ani AT; Chard T; Huang SC; Ouyang PC; Wei PY; Seppälä M
Am J Obstet Gynecol; 1981 Mar; 139(6):702-4. PubMed ID: 6971058
[TBL] [Abstract][Full Text] [Related]
19. Immunochemical and biochemical relationship between human pregnancy-associated secreted endometrial alpha 1- and alpha 2-globulins (alpha 1- and alpha 2-PEG) and the soluble placental proteins 12 and 14 (PP12 and PP14).
Bell SC; Bohn H
Placenta; 1986; 7(4):283-94. PubMed ID: 2428028
[TBL] [Abstract][Full Text] [Related]
20. Placental protein 5 (PP5): biological and clinical studies.
Salem HT; Chard T
Placenta Suppl; 1982; 4():103-14. PubMed ID: 6100760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
